ausblenden:
Schlagwörter:
Chemotactic Factors
Chemotaxis/*genetics
Cytoplasmic Vesicles/*metabolism
Drug Delivery Systems/*methods
Escherichia coli/genetics/*metabolism
Flagella/genetics
Gene Expression
Genetic Engineering/methods
Microorganisms, Genetically-Modified
Movement
Nanoparticles/*metabolism
Point Mutation
*chemotaxis
*drug delivery
*minicell
*motility
*nanoparticle
Zusammenfassung:
Minicells are nanosized membrane vesicles produced by bacteria. Minicells are chromosome-free but contain cellular biosynthetic and metabolic machinery, and they are robust due to the protection provided by the bacterial cell envelope, which makes them potentially highly attractive in biomedical applications. However, the applicability of minicells and other nanoparticle-based delivery systems is limited by their inefficient accumulation at the target. Here we engineered the minicell-producing Escherichia coli strain to overexpress flagellar genes, which enables the generation of motile minicells. We subsequently performed an experimental and theoretical analysis of the minicell motility and their responses to gradients of chemoeffectors. Despite important differences between the motility of minicells and normal bacterial cells, minicells were able to bias their movement in chemical gradients and to accumulate toward the sources of chemoattractants. Such motile and chemotactic minicells may thus be applicable for an active effector delivery and specific targeting of tissues and cells according to their metabolic profiles.
